ホーム › がん（全種類） › アラバマ州 › Birmingham
Birmingham、ALにおけるがん（全種類）の臨床試験
Birminghamとその周辺地域（約30マイル以内）の拠点で、がん（全種類）に関する30件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
被験者募集中第2/3相
- The Kirklin Clinic of UAB Hospital, Birmingham
- The University of Alabama at Birmingham, Birmingham
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
被験者募集中第3相
- UAB Medicine - UAB Hospital, Birmingham
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
被験者募集中第3相
- Quetzal Site 16, Birmingham
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
被験者募集中第3相
- Birmingham Hematology and Oncology Associates d/b/a Alabama Oncology /ID# 280063, Birmingham
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
被験者募集中第2相
- University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
被験者募集中第2/3相
- University of Alabama Birmingham, Birmingham
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
被験者募集中第2相
- UAB, Psychiatry and Behavioral Neurology, Birmingham
A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
被験者募集中第1/2相
- The University of Alabama at Birmingham ( Site 1005), Birmingham
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
被験者募集中第1相
- University of Alabama at Birmingham Cancer Center, Birmingham
Project: Every Child for Younger Patients With Cancer
被験者募集中観察研究
- Children's Hospital of Alabama, Birmingham
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
被験者募集中第2相
- Childrens Hospital of Alabama, Birmingham
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
被験者募集中第3相
- University of Alabama at Birmingham Cancer Center, Birmingham
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
被験者募集中第2相
- 004, Birmingham
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
被験者募集中第1相
- University of Alabama at Birmingham, Birmingham
A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers
被験者募集中
- University of Alabama at Birmingham, Division of Hematology and Oncology, Birmingham
A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
被験者募集中第1相
- GSK Investigational Site, Birmingham
Childhood Cancer Survivor Study
被験者募集中観察研究健康なボランティア歓迎
- University of Alabama at Birmingham/Children's of Alabama, Birmingham
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
被験者募集中
- Birmingham VA Medical Center, Birmingham, AL, Birmingham
Multisite Implementation of COMPRENDO
被験者募集中健康なボランティア歓迎
- Children's of Alabama/University of Alabama at Birmingham, Birmingham
Leading Healthy Eating and Activity Promotion Program
被験者募集中健康なボランティア歓迎
- University of Alabama at Birmingham, Birmingham
Video Inspired Discussions About Ethical Outcomes in Pediatrics
被験者募集中
- Children's of Alabama at Birmingham, Birmingham
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
被験者募集中第2相
- University of Alabama at Birmingham, Birmingham
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
被験者募集中
- University of Alabama at Birmingham, Birmingham
Evaluating the Implementation and Impact of Standard-of-care Delivered Oncology Financial Navigation
被験者募集中
- University of Alabama at Birmingham, Birmingham
TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
被験者募集中観察研究
- Alabama Oncology, Birmingham
Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
被験者募集中
- The Kirklin Clinic, Birmingham
GEMINI-NSCLC: NSCLC Biomarker Study
被験者募集中観察研究
- Alabama Oncology, Birmingham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
被験者募集中観察研究
- Massive Bio SYNERGY-AI site, Birmingham
BMT-CARE: Psychosocial Intervention for Transplant Caregivers
被験者募集中
- University of Alabama at Brimingham, Birmingham
Making Healthy Habits Stick
被験者募集中
- University of Alabama at Birmingham, Birmingham
他の都市におけるがん（全種類）の試験
- Houston, TX121件の研究
- New York City, NY110件の研究
- Boston, MA86件の研究
- Los Angeles, CA73件の研究
- Nashville, TN65件の研究
- Philadelphia, PA59件の研究
- Durham, NC58件の研究
- Washington, DC58件の研究
- Chicago, IL51件の研究
- Seattle, WA49件の研究
- Atlanta, GA49件の研究
- Arlington, VA48件の研究
Birminghamにおける他の研究
- 乳がん24件の研究
- 肥満症23件の研究
- 卵巣がん23件の研究
- 非小細胞肺癌22件の研究
- 急性骨髄性白血病21件の研究
- 多発性骨髄腫18件の研究
- COPD17件の研究
- 心血管疾患17件の研究
- 過体重16件の研究
- 子宮内膜がん16件の研究
- 2型糖尿病16件の研究
- 嚢胞性線維症16件の研究
ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。